139 related articles for article (PubMed ID: 8712840)
1. Abnormal serum porphyrin levels in patients with the acquired immunodeficiency syndrome with or without hepatitis C virus infection.
Nomura N; Zolla-Pazner S; Simberkoff M; Kim M; Sassa S; Lim HW
Arch Dermatol; 1996 Aug; 132(8):906-10. PubMed ID: 8712840
[TBL] [Abstract][Full Text] [Related]
2. Abnormal urinary coproporphyrin levels in patients infected by hepatitis C virus with or without human immunodeficiency virus. A study of 177 patients.
Cribier B; Rey D; Uhl G; Le Coz C; Hirth C; Libbrecht E; Vetter D; Lang JM; Stoll-Keller F; Grosshans E
Arch Dermatol; 1996 Dec; 132(12):1448-52. PubMed ID: 8961873
[TBL] [Abstract][Full Text] [Related]
3. Porphyrin abnormalities in acquired immunodeficiency syndrome.
O'Connor WJ; Murphy GM; Darby C; Fogarty J; Mulcahy F; O'Moore R; Barnes L
Arch Dermatol; 1996 Dec; 132(12):1443-7. PubMed ID: 8961872
[TBL] [Abstract][Full Text] [Related]
4. [Role of hepatitis C virus in porphyria cutanea tarda hepatopathy].
Quecedo L; Costa J; Enríquez de Salamanca R
Med Clin (Barc); 1996 Mar; 106(9):321-4. PubMed ID: 8667696
[TBL] [Abstract][Full Text] [Related]
5. Influence of hepatitis C virus (HCV) infection on porphyrin and iron metabolism in porphyria cutanea tarda (PCT) patients.
Dabrowska E; Jabłońska-Kaszewska I; Bielawski KP; Falkiewicz B
Med Sci Monit; 2001 May; 7 Suppl 1():190-6. PubMed ID: 12211718
[TBL] [Abstract][Full Text] [Related]
6. Porphyria cutanea tarda associated with human immunodeficiency virus infection.
Drobacheff C; Derancourt C; Van Landuyt H; Devred D; de Wazieres B; Cribier B; Rey D; Lang JM; Grosieux C; Kalis B; Laurent R
Eur J Dermatol; 1998; 8(7):492-6. PubMed ID: 9854161
[TBL] [Abstract][Full Text] [Related]
7. Epidemiology of hepatitis C and G in sporadic and familial porphyria cutanea tarda.
Lamoril J; Andant C; Bogard C; Puy H; Gouya L; Pawlotsky JM; Da Silva V; Soulé JC; Deybach JC; Nordmann Y
Hepatology; 1998 Mar; 27(3):848-52. PubMed ID: 9500716
[TBL] [Abstract][Full Text] [Related]
8. High prevalence of hepatitis C virus type 1b in Italian patients with Porphyria cutanea tarda.
Sampietro M; Fracanzani AL; Corbetta N; Amato M; Mattioli M; Molteni V; Fiorelli G; Fargion S
Ital J Gastroenterol Hepatol; 1997 Dec; 29(6):543-7. PubMed ID: 9513830
[TBL] [Abstract][Full Text] [Related]
9. Porphyria cutanea tarda, hepatitis C virus and selected symptoms of cholestasis.
Dabrowska E; Jabłońska-Kaszewska I; Bielawski KP; Podlaska M; Falkiewicz B
Med Sci Monit; 2001 May; 7 Suppl 1():185-9. PubMed ID: 12211717
[TBL] [Abstract][Full Text] [Related]
10. Cutaneous abnormalities and metabolic disturbance of porphyrins in patients on maintenance haemodialysis.
Gibson GE; McGinnity E; McGrath P; Carmody M; Walshe J; Donohoe J; O'Moore R; Murphy GM
Clin Exp Dermatol; 1997 May; 22(3):124-7. PubMed ID: 9425691
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis C (HCV) genotype and viral titer distribution among Argentinean hemophilic patients in the presence or absence of human immunodeficiency virus (HIV) co-infection.
Picchio GR; Nakatsuno M; Boggiano C; Sabbe R; Corti M; Daruich J; Pérez-Bianco R; Tezanos-Pinto M; Kokka R; Wilber J; Mosier D
J Med Virol; 1997 Jun; 52(2):219-25. PubMed ID: 9179772
[TBL] [Abstract][Full Text] [Related]
12. Early-stage HIV infection and hepatitis C virus infection are associated with elevated serum porphyrin levels.
Lim HW; Pereira A; Sassa S; Kim M; Zolla-Pazner S
J Am Acad Dermatol; 1998 Dec; 39(6):956-9. PubMed ID: 9843008
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis C virus and human immunodeficiency virus infection can alter porphyrin metabolism and lead to porphyria cutanea tarda.
Blauvelt A
Arch Dermatol; 1996 Dec; 132(12):1503-4. PubMed ID: 8961882
[No Abstract] [Full Text] [Related]
14. Bullous dermatosis of end-stage renal disease: a possible association between abnormal porphyrin metabolism and aluminium.
Gafter U; Mamet R; Korzets A; Malachi T; Schoenfeld N
Nephrol Dial Transplant; 1996 Sep; 11(9):1787-91. PubMed ID: 8918623
[TBL] [Abstract][Full Text] [Related]
15. Autoimmunity and HCV infection in porphyria cutanea tarda: a controlled study.
Stölzel U; Schuppan D; Tillmann HL; Manns MP; Tannapfel A; Doss MO; Zimmer T; Köstler E
Cell Mol Biol (Noisy-le-grand); 2002 Feb; 48(1):43-7. PubMed ID: 11929046
[TBL] [Abstract][Full Text] [Related]
16. The prevalence of hepatitis C in patients with porphyria cutanea tarda in Stockholm, Sweden.
Linde Y; Harper P; Floderus Y; Ros AM
Acta Derm Venereol; 2005; 85(2):164-6. PubMed ID: 15823914
[TBL] [Abstract][Full Text] [Related]
17. [Porphyrin excretion in patients with chronic hepatitis C virus infection].
Armas-Merino R; Wolff C; Parraguez A; Soto JR
Rev Med Chil; 1997 Mar; 125(3):279-82. PubMed ID: 9460263
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of hepatitis B virus and hepatitis C virus co-infection with human immunodeficiency virus in Thai patients: a tertiary-care-based study.
Sungkanuparph S; Vibhagool A; Manosuthi W; Kiertiburanakul S; Atamasirikul K; Aumkhyan A; Thakkinstian A
J Med Assoc Thai; 2004 Nov; 87(11):1349-54. PubMed ID: 15825712
[TBL] [Abstract][Full Text] [Related]
19. Impact of occult hepatitis B virus infection and prior hepatitis B virus infection on development of hepatocellular carcinoma in patients with liver cirrhosis due to hepatitis C virus.
Adachi S; Shibuya A; Miura Y; Takeuchi A; Nakazawa T; Saigenji K
Scand J Gastroenterol; 2008; 43(7):849-56. PubMed ID: 18584524
[TBL] [Abstract][Full Text] [Related]
20. [Porphyria cutanea tarda and hepatitis C virus infection. Clinical and virological study].
Cribier B; Petiau P; Stoll-Keller F; Schmitt C; Vetter D; Heid E; Grosshans E
Ann Dermatol Venereol; 1996; 123(3):200-2. PubMed ID: 8761787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
